schizophrenia Clinical Trials and Research
Also known as: schizophrenic disorder, psychotic disorder, thought disorder, schizophrenia spectrum, chronic psychosis · ICD-10: F20
Schizophrenia is a chronic brain disorder that affects how a person thinks, feels, and behaves, often leading to a distorted perception of reality. Clinical trial research is focused on developing new treatments, understanding its causes, and improving symptom management. Find a Trial helps patients search for active studies.
Common questions about schizophrenia clinical trials
Who can participate in schizophrenia clinical trials?
Eligibility criteria vary by study but often include age, a confirmed diagnosis, and specific symptom profiles. Researchers use these criteria to ensure patient safety and collect relevant data, as found on ClinicalTrials.gov. Each trial has unique requirements.
What are the different phases of clinical trials for schizophrenia?
Clinical trials for schizophrenia typically progress through phases 1, 2, and 3. Phase 1 tests safety, phase 2 evaluates effectiveness and side effects, and phase 3 compares new treatments to existing ones. This structured process is outlined on ClinicalTrials.gov.
What new treatments are being studied for schizophrenia?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores novel antipsychotics, cognitive remediation therapies, and treatments targeting specific symptoms like cognitive deficits. Studies also investigate non-pharmacological interventions and digital health tools for managing the condition.
What types of interventions are commonly tested in schizophrenia trials?
Trials frequently test new medications, including atypical antipsychotics and glutamatergic modulators. Psychosocial interventions, such as cognitive behavioral therapy and social skills training, are also common. Data from ClinicalTrials.gov shows a range of pharmacological and non-pharmacological approaches.
Are there specific biomarkers being studied in schizophrenia research?
Yes, researchers are investigating genetic markers, neuroimaging findings (like MRI scans), and certain blood-based indicators as potential biomarkers. These help understand disease mechanisms and predict treatment response, according to information from NIH RePORTER.
Do participants in schizophrenia clinical trials have to pay?
Generally, participants do not pay for study-related treatments or procedures. Often, some travel or other expenses may be reimbursed. Specific financial details are provided in the informed consent document for each trial, as noted on ClinicalTrials.gov.
What are common reasons someone might not be eligible for a schizophrenia trial?
Common exclusion criteria include co-occurring severe medical conditions, active substance abuse, or a history of certain neurological disorders. Specific criteria vary, but they ensure participant safety and study integrity, as detailed on ClinicalTrials.gov for individual trials.
How do clinical trials for schizophrenia impact daily life?
Participating in a trial may involve regular clinic visits, taking study medication, and completing assessments. The impact varies by study design and duration, but researchers aim to minimize disruption. Detailed expectations are provided during the informed consent process, available on ClinicalTrials.gov.
How to find a schizophrenia trial that fits you
- Describe your schizophrenia situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all schizophrenia trials →